Previous Chapter Chapter 126: US Markets for Varicose Vein Treatment Next Chapter

  • Citations
  • Add to My List
  • Text Size

US Markets for Varicose Vein Treatment
US markets for varicose vein treatment
Millennium Research Group, A Decision Resources, Inc. Company

In 2005, the US market for varicose vein treatment devices was valued at nearly $100 million and is expected to grow over 10% by 2010. This market consists of greater saphenous vein (GSV) treatments, endovenous laser ablation (ELA), endovenous radio frequency ablation (ERFA), and surgical stripping, as well as non-GSV treatments of phlebectomy and sclerotherapy. The varicose vein treatment market will be driven by minimally invasive surgical (MIS) procedures due to better Medicare and private insurance reimbursements. For instance, ELA and ERFA procedures will cannibalize GSV treatments that have been traditionally treated with surgical stripping. Within the MIS market, historic dominance of ERFA over ELA ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website